Litigation Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
✉ Email this page to a colleague
Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-26 |
| Court | District Court, N.D. West Virginia | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Patents | 6,551,620; 8,337,886; 8,496,965; 8,865,688 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-12 | 117 | These include: Patent No. 6,551,620 (“the ‘620 Patent”); Patent No. 8,337,886 (“…the ‘886 Patent”); Patent No. 8,496,965 (“the ‘965 Patent”); and 8,865,688 (“the ‘688 Patent”). The …CONSTRUING PATENT CLAIMS This patent infringement case involves four United States patents issued …‘620, ‘886, and ‘965 Patents, collectively referred to as the Otterbeck patents,1 contain two disputed…dispute one claim term in the ‘688 Patent. The Otterbeck patents cover a controlled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
